Xilio Therapeutics, Inc.XLONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
23.44%
↑ 167% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthAccelerating
Average
-34.74%
Historical baseline
PeriodValue
202423.44%
202311.24%
2022-18.80%
2021-37.54%
2020-186.77%
20190.00%